TRxADE Health, Inc. Announces Special Cash Dividend

Rhea-AI Summary

TRxADE HEALTH Inc. (MEDS) declares a special cash dividend of $8.00 per share of common stock, funded by the sale of web-based market platform assets.

Positive

• TRxADE HEALTH Inc. declares a generous special cash dividend of $8.00 per share, showcasing commitment to shareholder value.
• The dividend is funded by the proceeds from the recent sale of the Company's web-based market platform assets, indicating strategic financial planning.
• Stockholders of record as of March 18, 2024, are eligible to receive the special cash dividend, enhancing investor confidence.
• The special dividend payment reflects the Company's focus on rewarding shareholders and utilizing asset sales to benefit investors.

Negative

• None.

Financial Analyst

TRxADE HEALTH Inc.'s declaration of a special cash dividend of $8.00 per share is a substantial return to shareholders, particularly when considering the average dividend yield within the healthcare sector. This move likely indicates that the company's management believes they have excess capital sufficient to reward shareholders without compromising their operational liquidity or investment in growth opportunities.

Investors should note that such a sizable dividend could be a signal of strong financial health or a strategic decision following a significant asset sale. The payment of this dividend may lead to a short-term increase in stock price due to the dividend capture strategy employed by some investors. However, it's also important to monitor the long-term effects on the company's stock, as the market adjusts to the reduced cash reserves post-dividend payout.

Market Research Analyst

The sale of TRxADE HEALTH's web-based market platform assets and subsequent special dividend announcement could suggest a strategic pivot or realignment of the company's business model. It's essential to analyze the potential impact on the company's competitive position within the healthcare technology market.

Analyzing the company's past performance and comparing it with industry benchmarks can provide insights into whether this was a one-time gain or part of a larger trend of asset liquidation. The market's response to this news can also serve as a barometer for investor sentiment regarding the company's future growth prospects and operational strategy.

Economist

From an economic perspective, the injection of cash into the market through a special dividend can have ripple effects on consumer spending and investment patterns, particularly in the local economy where the company's shareholders may reside. The timing and magnitude of this dividend payout should be assessed in the context of the current economic cycle and monetary policy environment to gauge its potential impact on inflation, interest rates and overall market liquidity.

TAMPA, FL, March 06, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH Inc. (Nasdaq: MEDS) (the “Company”), announced that the Company’s board of directors has declared a special cash dividend of $8.00 per share of common stock. The special dividend is being paid using a portion of the proceeds from the closing of the recently announced sale of the Company’s web-based market platform assets. The special cash dividend is payable to stockholders of record as of March 18, 2024, with the dividend being paid on or about March 22, 2024.

Forward-Looking Statements

This press release contains certain statements that may be deemed to be “forward-looking statements” within the federal securities laws, including the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Statements that are not historical are forward- looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements relate to future events or our future performance or future financial condition. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about our Company, our industry, our beliefs and our assumptions. Such forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” or the negative of these terms or other similar expressions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are subject to a number of risks and uncertainties (some of which are beyond our control) that may cause actual results or performance to be materially different from those expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. These risks include risks relating to agreements with third parties; our ability to raise funding in the future, as needed, and the terms of such funding, including potential dilution caused thereby; our ability to continue as a going concern; security interests under certain of our credit arrangements; our ability to maintain the listing of our common stock on the Nasdaq Capital Market; claims relating to alleged violations of intellectual property rights of others; the outcome of any current legal proceedings or future legal proceedings that may be instituted against us; unanticipated difficulties or expenditures relating to our business plan; and those risks detailed in the Company’s most recent Annual Report on Form 10-K and subsequent reports filed with the Securities and Exchange Commission.

Forward-looking statements speak only as of the date they are made. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, except as otherwise provided by law.

Investor Contact:

TRxADE Health, Inc.
2420 Brunello Trace
Lutz, Florida 33558
Email: IR@trxade.com

What is the special cash dividend declared by TRxADE HEALTH Inc. (MEDS)?

TRxADE HEALTH Inc. has declared a special cash dividend of $8.00 per share of common stock.

How is the special dividend being funded by TRxADE HEALTH Inc. (MEDS)?

The special cash dividend is being funded by a portion of the proceeds from the recently announced sale of the Company's web-based market platform assets.

When will the special cash dividend be paid to stockholders of TRxADE HEALTH Inc. (MEDS)?

The special cash dividend will be paid to stockholders of record as of March 18, 2024.

What does the declaration of a special dividend by TRxADE HEALTH Inc. (MEDS) indicate?

The declaration of a special cash dividend indicates the Company's commitment to rewarding shareholders and utilizing asset sales for investor benefit.